x

Search for a clinical trial

* (*) mandatory field

TARMIC : Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly trabectedin combined with Metronomic Cyclophosphamide in Patients with Advanced Pretreated Soft-tissue Sarcomas. A Phase I/II study from the French Sarcoma Group

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Institut bergonie
  • Website
    • Phase : I - II
  • Principal investigator of clinical trial

  • Pr Antoine ITALIANO
  • Département d'oncologie médicale - Groupe Sarcomes
  • CLCC Institut Bergonié
  • 229 Cours de l'Argonne
  • 33076 BORDEAUX
  • FRANCE
  • More information
  • Phone  : 33 (0)5 56 33 32 78
  • Fax  : 33 (0)5 56 33 33 85
  • Website
  • Sponsor of clinical trial

  • INSTITUT BERGONIE
  • Bureau d'études cliniques
  • CLCC Institut Bergonié
  • 229 Cours de l'Argonne
  • 33076 BORDEAUX
  • FRANCE
  • More information
  • Phone  : 33 (0)5 56 33 32 51
  • Fax  : 33 (0)5 56 33 33 81
  • Website
Last update: September 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.